HuGE Literature Finder
Records 1-6
TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis.
Molecular and clinical oncology 2016 Dec 5 (6): 705-713. Gu Jincui, Zhou Yanbin, Huang Lixia, Ou Weijun, Wu Jian, Li Shaoli, Xu Junwen, Feng Jinlun, Liu Bao |
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.
Gut 2016 Jan . Fisher Oliver M, Lord Sarah J, Falkenback Dan, Clemons Nicholas J, Eslick Guy D, Lord Reginald |
The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
Lung 2013 Aug 191 (4): 369-77. Qiao Qian, Hu Weig |
Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2010 Jul 19 (4): 299-307. Wang Bin, Wang Dan, Zhang Deqiang, Li Aijun, Liu Dawei, Liu Hu, Jin H |
TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.
International journal of cancer. Journal international du cancer 2009 Dec 125 (12): 2903-11. Yan Lili, Zhang Deqiang, Chen Chengwen, Mao Yumin, Xie Yi, Li Yao, Huang Yan, Han Baoh |
A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
Lung cancer (Amsterdam, Netherlands) 2009 Oct 66 (1): 15-21. Li Yan, Qiu Li-Xin, Shen Xiao-Kun, Lv Xiao-Jing, Qian Xiao-Ping, Song Yo |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: